लोड हो रहा है...
Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity
Low-dose metronomic chemotherapy is a promising therapeutic cancer treatment strategy thought to have an antiangiogenic basis. However, the advantages of reduced toxicity, increased efficacy in some cases, and ability to combine chemotherapy administered long term in this way with targeted therapies...
में बचाया:
| मुख्य लेखकों: | , , , , , , |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
The American Society of Hematology
2005
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1895327/ https://ncbi.nlm.nih.gov/pubmed/15998832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2005-04-1422 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|